Compare Merck & Co., Inc. (MRK) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while Direxion Daily Semiconductor Bear 3X Shares trades at $34.39 (market cap $1.96B). The key difference: Merck & Co., Inc. is far larger — about 179.2× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| MRK | SOXS | |
|---|---|---|
Market Cap | $351.28B | $1.96B |
Volume | 7,969,665 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $156.43 | $988.00 |
52-Week Low | $82.49 | $29.62 |
Typical Hold Time | 98 Days | 11 Days |
Enterprise Value | $398.04B | — |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $65.01 billion in 2025, and net income reached $18.25 billion. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, with institutional investors increasing stakes.
The outlook for Merck is supported by analyst consensus with a $158.78 price target and 68% buy ratings, but risks include high valuation multiples like a P/E of 113.9 and competitive pressures in the pharma sector. The stock's investment appeal hinges on pipeline execution and integration of acquisitions amid a challenging technical backdrop.
SOXS (Direxion Daily Semiconductor Bear 3X ETF) trades at $33.78, up 10.23% with a bearish technical signal overall. The ETF shows mixed indicators with moving averages signaling bearish momentum while oscillators remain neutral. Recent corporate actions include a 1:10 stock split effective July 15, 2026, and a scheduled dividend payment in September 2026. The semiconductor sector faces volatility amid AI demand shifts and competitive pressures.
Outlook remains cautious given SOXS's inverse leveraged structure and semiconductor sector headwinds. Investment opportunity exists for tactical bearish positions on chip sector weakness, but risks include high volatility and timing challenges. Persistent AI hardware demand could limit sustained bearish performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
